I C U Medical Inc (ICUI) 115.00 $ICUI Illumina Stock Hit

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 6:01 AM

I C U Medical Inc (ICUI) 115.00 $ICUI

Illumina Stock Hit by Downbeat Guidance, Stiff Competition
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:27AM CDT
Illumina (ILMN) faces high expenses related to the development of new products, their launch in various markets and investments in partnerships
ICUI: 115.00 (+1.34), NXTM: 22.91 (+1.07), GWPH: 94.83 (+1.36), ILMN: 141.25 (+1.19)

Halyard Health Now a Strong Buy, Portfolio Key Catalyst
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:54AM CDT
On Jul 8, 2016, Zacks Investment Research upgraded Halyard Health Inc (HYH) to a Zacks Rank #1 (Strong Buy).
HYH: 34.47 (+1.10), DSCI: 4.22 (+0.15), ICUI: 115.00 (+1.34), NXTM: 22.91 (+1.07)

Henry Schein Rides High on Strategic Buyouts, Price Hurts
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Henry Schein's (HSIC) latest acquisition development includes the completion of its takeover of 50% interest in J Morita's subsidiary, One Piece Corp.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), HSIC: 180.72 (+2.74), NUVA: 60.82 (+1.11)

Walgreens Boots Tops Q3 Earnings, Rite Aid Deal on Track
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 10:46AM CDT
Walgreens Boots (WBA) reported a mixed third-quarter fiscal 2016 with earnings comfortably beating the Zacks Consensus Estimate, while the top line closely missed the mark.
ICUI: 115.00 (+1.34), WBA: 81.80 (+1.30), GWPH: 94.83 (+1.36), TGTX: 6.16 (+0.05)

Zimmer Biomet Poised on LDR Inclusion, Product Launches
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:12AM CDT
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), ZBH: 124.89 (+2.87), NUVA: 60.82 (+1.11)

Abaxis: Growth on Test Menu Expansion; Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:38AM CDT
Abaxis (ABAX) has been working on expanding its portfolio of rapid test menu over the recent past.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), ABAX: 50.95 (+2.54), NUVA: 60.82 (+1.11)

NuVasive (NUVA) at 52-Week High on Strategic Initiatives
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 8:03AM CDT
Currently, NuVasive (NUVA) expects its international business to grow by 38% in 2016, at CER.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), GWPH: 94.83 (+1.36), NUVA: 60.82 (+1.11)

Akers Biosciences Chlamydia Rapid Test Results Positive
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:33AM CDT
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), CAH: 80.38 (+0.94), AKER: 2.79 (+0.09)

Myriad Genetics: Study Data Drives Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:51AM CDT
Most recent study data from the Nova trial shows Myriad's (MYGN) myChoice HRD test's effectiveness in detecting an increased number of ovarian cancer patients
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), MYGN: 31.69 (+0.81), LMAT: 13.70 (+0.14)

GNC Holdings' Overseas Prospects Robust Amid Market Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 4:35PM CDT
On Jun 30, 2016, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), GNC: 25.53 (+0.81), STJ: 80.58 (+0.43)

Medtronic (MDT) Focuses on Cardiac Management Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:00AM CDT
Following the release, shares of Medtronic gained 1.56% to reach $85.45 at the end of yesterday's trading session.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), MDT: 88.36 (+0.87), STJ: 80.58 (+0.43)

Baxter International: Health Canada Okays AMIA APD System
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Baxter International Inc. (BAX) is forging ahead with its expansion plans in Canada with the launch of AMIA Automated Peritoneal Dialysis (APD) System.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), BAX: 46.65 (+0.53), NUVA: 60.82 (+1.11)

Illumina, MolecularMD to Co-Develop Oncology Diagnostics
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:07AM CDT
The collaboration will combine Illumina's (ILMN) expertise in NGS technology with MolecularMD's experience in developing molecular testing for new oncology drugs
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), LMAT: 13.70 (+0.14), ILMN: 141.25 (+1.19)

STERIS: Synergy Health Deal to Drive Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:05AM CDT
Management expects the Synergy acquisition to contribute $640 million to $650 million in revenues to STERIS' (STE) operations in fiscal 2017.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), STE: 69.16 (+0.97), LMAT: 13.70 (+0.14)

Medtronic Positive on HeartWare Buy, Covidien Synergies
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 7:25AM CDT
On Jun 28, 2016, we issued an updated research report on Medtronic plc (MDT).
ICUI: 115.00 (+1.34), MDT: 88.36 (+0.87), LMAT: 13.70 (+0.14), NUVA: 60.82 (+1.11)

Bruker Poised on Product Launches amid Near-Term Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 7:12AM CDT
On Jun 29, we issued an updated research report on Bruker Corporation (BRKR).
ICUI: 115.00 (+1.34), LMAT: 13.70 (+0.14), BRKR: 23.68 (+0.24), NUVA: 60.82 (+1.11)

Medtronic to Boost Heart Failure Business with HeartWare Buy
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 7:11AM CDT
Medtronic (MDT) recently entered into a merger agreement with Heartware International for the treatment of advanced heart failure.
ICUI: 115.00 (+1.34), MDT: 88.36 (+0.87), LMAT: 13.70 (+0.14), HTWR: 57.64 (+0.11)

Akers Biosciences Signs Distribution Agreement, Shares Rally
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 6:49AM CDT
Akers Biosciences Inc. (AKER) recently signed an agreement with Aero-Med, a division of Cardinal Health (CAH), to distribute its disposable breathalyzer.
BSX: 23.90 (+0.24), ICUI: 115.00 (+1.34), CAH: 80.38 (+0.94), AKER: 2.79 (+0.09)

ResMed : All Eyes on Brightree Buyout , Growth Plans on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 9:11AM CDT
ResMed's partnership with Brightree will expand its Air solutions platform thus increasing its end-to-end value proposition by boosting its SDB products.
ICUI: 115.00 (+1.34), BAX: 46.65 (+0.53), ENZY: 8.63 (+0.28), RMD: 64.51 (+1.16)

FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 6:31AM CDT
With surgical procedures gaining ground in the treatment of drug-resistant epilepsy, the FDA go-ahead will expand Medtronic's (MDT) footprint in the billion-dollar neurosurgical market.
ICUI: 115.00 (+1.34), MDT: 88.36 (+0.87), BAX: 46.65 (+0.53), LMAT: 13.70 (+0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Masimo's smartSET™ Revolutionizes Patient Monitoring

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

LG OLED evo W6: UAE Roadshow Starts with a Bang

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Hyliion Class Action Deadline Nears for Investors

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Voter Events by Valley Community Healthcare Aim to Empower

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Innventure Faces Major Lawsuit Over Misleading Investors

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Weifang's Cultural Resurgence: A Global Epigraphy Fest

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...